I
m going to turn 40 this month, a milestone Im approaching with nine-tenths equanimity, one-tenth mild existential dread.
On the one hand, with a kid and a job, Im too busy to spend much time peering at my newly middle-aged navel. Plus, if youre lucky enough to be healthy, griping about simply growing older is churlish. On the other, there is an undeniable psychic wrench in the realisation that I now tick the aged 40-60 box. Somehow, I seem to have lurched from young and clueless to the age where people will make jokes about the number of candles on my cake, without an intervening period of solid competence. I still run for the bus. I can still never find the lids for the Tupperware. I am older than the prime minister of Finland, but I cant reliably pair my own socks. I dont feel fully grown up, and yet there is the creeping sense that, as Sue Townsend put it via her timeless mouthpiece Adrian Mole, Im on a pathetic slide towards gum disease, wheelchair ramps and death.
But is this slide inevitable? Thats the central question of Ageless: The New Science of Getting Older Without Getting Old, an ambitious and energetic new book by the scientist and writer Andrew Steele. While hes not peddling some holy grail of immortality, he does give a startling round-up of the biological factors that make us age and the emerging techniques to tackle them, offering the prospect of both longer and healthier lives.
To start with some perspective: human lifespans vary hugely based on time and place, with life expectancy under the age of 40 the norm everywhere at the start of the 19th century, largely due to high child mortality. Drawing examples from the animal kingdom, Steele points out that innings vary from five minutes for a mayfly to 400 years for a Greenland shark. We are, of course, neither flies nor sharks. But if we accept the idea that a human life isnt capped at 82 and pursue all the opportunities of frontier research, perhaps we could become more like tortoises. As Steele explains, the Galapagos tortoise, along with a handful of other blessed oddballs in the natural world, are negligibly senescent meaning they have no obvious impairments of movement or senses as they get older, and they experience no age-related declines in fertility.
They dont live forever. But referring to a giant tortoise discovered by Charles Darwin who lived until 2006, Steele writes: Harriet was likely pretty much as sprightly at 170 as she was at 30, at the height of Queen Victorias reign which is to say, not very; she was a giant tortoise, after all.
This liveliness of tone helps to carry the reader through an unsparing account of the toll ageing takes on the human body. The comic writer Nora Ephron may have called her mature memoir I Feel Bad About My Neck, but ageing emerges from this book as less aesthetic challenge, more devastating, systemic collapse. The gloomiest statistic of the lot? Your chance of death doubles every eight years, as a range of processes make us progressively more susceptible to big killers like cancer, heart disease, stroke, dementia and diabetes.
Steele gives a jauntily accessible account of the mechanisms behind our decline. One overarching driver is disposable soma theory: the evolutionary logic that prioritises the health of our reproductive cells over the soma cells which make up our own bodies. I had always suspected that having a child somehow drained me of my life force: here is the evidence. And as our neglected soma cells age, things go wrong. Our telomeres, protective caps on our chromosomes which are essential for healthy cell division, get shorter. Autophagy the process by which cells clear out their own junk declines. Proteins misfold into sticky clumps that risk forming the plaques behind Alzheimers disease. Frail old cells linger: They stick around, no longer dividing aged, zombie cells which refuse to commit cell suicide, known as senescent cells. Our mitochondria which give cells energy misfunction. Stem cells falter. Chronic inflammation ups the risk of everything from diabetes to cancer. Its a startling wake-up call that there are worse things bubbling away in your biology than a few grey hairs, or the frown lines that make every Zoom call of this pandemic a harrowing ordeal for the over-35s.
Independent Culture NewsletterThe best in film, music TV & radio straight to your inbox every week
Independent Culture NewsletterThe best in film, music TV & radio straight to your inbox every week
But what if there was another way? Dont book your return trip to the moon for 2125 just yet. The science has a long way to go: as Steele points out, most of the research is in its early stages, bristling with the potential for pitfalls and unintended consequences. But there are a number of approaches that hold promise, with todays huge advances in computing spurring new therapies. Steele posits that senolytics, or drugs that destroy senescent cells, could be with us in the next few years, albeit to tackle age-related conditions rather than ageing itself. After that, more advanced treatments like gene and stem cell therapies could be available on timescales measured in decades. Ultimately, instead of tackling the individual symptoms of ageing a creaky knee here, a furred-up artery there we will move towards systems medicine that stops us falling to bits in the first place:
The first ageless generation probably wont realise their luck at first theyll grow up expecting to die at 100, or 150, or whatever old is for their society but, one after another, lifesaving medical breakthroughs will push their funerals further and further into the future.
Steele writes with the maverick confidence of the outside perspective. He took a PhD in physics, then moved into computational biology before pursuing his interest in ageing as a writer. In this career switch, he has something in common with Aubrey de Grey, the bearded high priest of the anti-ageing movement who began with a background in computer science. While Steele stops short of making outlandish predictions de Grey famously ruffled academic feathers with his claim people could live to be 1,000 the logic is the same.
While we would all merrily jettison our wrinkles and give bowel cancer a miss, are we really ready for an ageless society, presuming the science stacks up? Steele writes quite reasonably that no one would invent the suffering of old age as a solution to an over-crowded world, but this research nonetheless opens up a fascinating Pandoras box of challenges. Rather than a utopia of dewy-faced centenarians hover-boarding to work, we would probably first see a deepening of the grotesque inequalities that already exist in health today. Theres currently a nine-year gap in lifespans between the richest and poorest parts of the UK. Add some fancy preventive drugs to the mix and you can guess who would get them first. Moreover, with ageism rife in the workplace, especially in the tech industry which provides an increasing number of jobs, who could afford not to quaff the pills that keep you looking fresh in your hoodie?
Writing with the vim of a Bill Bryson and the technical knowledge of a scientist, Steele at least gives us a chance to grasp whats at stake in this dazzling, daunting age where big data meets human biology. Negligible senescence may remain a stretch for my New Years resolutions, but Id happily progress at a more tortoise-like pace towards the next milestones of decrepitude.
Read the rest here:
Science can stop us ageing, according to a new book. But do we want it to? - The Independent
- Breast Cancer Is Most Common Cancer In India, 1.38 Million Cases Diagnosed Annually. Know Estimated Incidence By 2030 - ABP Live - November 26th, 2023
- What Is Amyloidosis? All About The Rare Disease That Pervez Musharraf Suffered From - ABP Live - February 8th, 2023
- Autophagic death of neural stem cells mediates chronic stress-induced ... - November 7th, 2022
- Programmed cell death - Wikipedia - November 7th, 2022
- Hematopoietic Stem Cells | Hematopoiesis | Properties & Functions - September 4th, 2022
- Canadian Blood Services Stem Cells for Life - September 4th, 2022
- Devastation over death of schoolgirl, 11, who hoped she was beating cancer - Leicestershire Live - September 4th, 2022
- From optimized stem cell transplants to CAR T cell therapy: Advancing options for cancer, HIV and more - City of Hope - September 4th, 2022
- Scientists unlock the key to immortality in jellyfish - Syfy - September 4th, 2022
- Forge Biologics Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients... - September 4th, 2022
- Menin Inhibitors Have Potential to Become the Next Class of Targeted Therapy in AML - Targeted Oncology - September 4th, 2022
- Wanted murder suspect John Belfield believed to still be in the UK as two more arrested over death of Thomas Campbell - The Manc - September 4th, 2022
- Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study | Blood Cancer Journal... - July 8th, 2022
- Can minds persist when they are cut off from the world? - Livescience.com - July 8th, 2022
- Black Adolescent Young Adults With AML Have Worse Outcomes Vs White Population - Cancer Network - July 8th, 2022
- Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in... - July 8th, 2022
- How abortion ruling could affect IVF and embryonic research - The Almanac Online - July 8th, 2022
- This Morning viewers 'in tears' after boy meets donor who saved his life - Devon Live - July 8th, 2022
- Alpena detective: 'Good people out there' | News, Sports, Jobs - Alpena News - July 8th, 2022
- 'I miss my best friend': Five-year-old runs 10k to honour girl who died from rare brain tumour - Teesside Live - July 8th, 2022
- Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by... - July 8th, 2022
- Novartis AG, AstraZeneca Plc, and Pfizer Inc Among Leading Companies in the Thyroid Cancer Pipeline Products Market | Globaldata Plc - Yahoo Finance - July 8th, 2022
- A New Strategy Could Turn the Tide in Stem Cell GVHD - Medical Device and Diagnostics Industry - January 17th, 2022
- Vertex type 1 diabetes vs stem cell therapy - The Boar - January 17th, 2022
- Two-Year OS Doubles for Patients With Philadelphia-Positive Relapsed ALL After HSCT - AJMC.com Managed Markets Network - January 17th, 2022
- Nowakowski Considers CD19 Therapy in Transplant-Ineligible DLBCL - Targeted Oncology - January 17th, 2022
- Psaki demolishes Doocy with stats as he tries to claim covid now an illness of the vaccinated - newsconcerns - January 17th, 2022
- Doctors and Researchers Probe How COVID-19 Attacks the Heart - The Scientist - January 17th, 2022
- Who does donated blood that's direly needed help? - WTOP - January 17th, 2022
- Places Where Omicron is Most Contagious Eat This Not That - Eat This, Not That - January 17th, 2022
- UHN and U of T receive $24-million federal grant for transplant research - News@UofT - January 17th, 2022
- Glycyrrhizic acid ameliorates submandibular gland oxidative stress, autophagy and vascular dysfunction in rat model of type 1 diabetes | Scientific... - January 17th, 2022
- Stem cells in cancer therapy: opportunities and challenges - January 1st, 2022
- Life After Brain Death: Is the Body Still 'Alive'? | Live ... - January 1st, 2022
- Autologous Adult Stem Cells in the Treatment of Stroke | SCCAA - Dove Medical Press - January 1st, 2022
- Stem Cell Mimicking Nanoencapsulation for Targeting Arthrit | IJN - Dove Medical Press - January 1st, 2022
- Cellular Therapies Fill Unmet Needs in R/R Multiple Myeloma - Targeted Oncology - January 1st, 2022
- Upregulated expression of actin-like 6A is a risk factor | CMAR - Dove Medical Press - January 1st, 2022
- COVID-19 Takes a Toll on People with Blood Cancers and Disorders - Cancer Health Treatment News - January 1st, 2022
- Mental health disorders and heart diseases - Rising Kashmir - January 1st, 2022
- Research breakthrough could mean better treatment for patients with most deadly form of brain tumor - EurekAlert - October 26th, 2021
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy as Treatment for Certain Patients With Locally Recurrent Unresectable... - October 26th, 2021
- European Commission Selects Humanigen's Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 - Galveston County Daily News - October 26th, 2021
- Everything You Need To Know About COVID Booster Shots - Colorado Times Recorder - October 26th, 2021
- Stem cells and their role in lung transplant rejection - Michigan Medicine - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Will humans ever be immortal? - Livescience.com - October 5th, 2021
- Healthcare Researchers Are Putting HUMAN Immune Systems In Pigs To Study Illnesses-Here's The Tech Behind It - Tech Times - October 5th, 2021
- Why Bezos, Musk, Page and other billionaires want to live forever - New York Post - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - ABC 12 News - October 5th, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 5th, 2021
- Skeletons' broken clavicles tell a centuries-old tale of humans and horses - Massive Science - October 5th, 2021
- Environmental Factor - August 2021: Extramural Papers of the Month - Environmental Factor Newsletter - August 4th, 2021
- Role of traumatic brain injury in the development of glioma | JIR - Dove Medical Press - August 4th, 2021
- Targeted Therapeutics Market: Increase in Incidence of Cancer to Drive Global Market - BioSpace - August 4th, 2021
- Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Ca | CMAR - Dove Medical Press - August 4th, 2021
- Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients with Multiple Myeloma - Curetoday.com - June 7th, 2021
- Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver - Science Advances - June 7th, 2021
- Cancer research: New advances and innovations - Medical News Today - June 7th, 2021
- Fulvestrant Alone Found to be Superior to Venetoclax/Fulvestrant Combo in ER+/HER2- Breast Cancer - Targeted Oncology - June 7th, 2021
- Merck's KEYTRUDA Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal... - June 7th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 14th, 2021
- The race to treat a rare, fatal syndrome may help others with common disorders like diabetes - Science Magazine - February 14th, 2021
- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with... - February 14th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 14th, 2021
- Arlo's Army needs stem cell donor as mum begs for help to save three-year-old's life - Glasgow Live - February 14th, 2021
- Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV (enfortumab vedotin-ejfv) in Patients with Previously... - February 14th, 2021
- [Full text] Successful Use of Nivolumab in a Patient with Head and Neck Cancer Aft | OTT - Dove Medical Press - February 14th, 2021
- The drug treatments offering the best hope of a way out of the Covid crisis - Telegraph.co.uk - February 14th, 2021
- In the war against Covid, an arsenal of drugs is on the way - Telegraph.co.uk - February 14th, 2021
- Kat Wests husband, Jeff West, sentenced to 16 years in wifes death - AL.com - February 9th, 2021
- Harnessing the Potential of Cell and Gene Therapy - OncLive - February 9th, 2021
- I Survived Cancer, and Then I Needed to Remember How to Live - The Atlantic - February 9th, 2021
- [Full text] Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor f | CMAR - Dove Medical Press - February 9th, 2021
- West Belfast woman to be remembered in special TV documentary - Belfast Live - January 29th, 2021
- UTV documentary tells of young Belfast woman's lasting legacy to promote stem cell donation - The Irish News - January 29th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 29th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 29th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 29th, 2021
- Experimental taphonomy of organelles and the fossil record of early eukaryote evolution - Science Advances - January 29th, 2021